Logan Lutton

In this interview, Emma Kaplan-Lewis, M.D., clinical quality director for HIV, hepatitis and sexual health services at NYC Health + Hospitals, discusses the results of her latest case study on PrEP uptake and why it’s important to “celebrate success.”

In this interview, Danielly Fausto, Ph.D., physical education researcher at the Santa Catarina State University in Brazil, discusses the importance of midlife physical activity, how she’s come to terms with the initially "disappointing" results of her recent study and why it’s essential to keep talking about menopause.

Sleep deprivation of 21 hours or more significantly reduces cooperation and overall team performance, causing individuals to prioritize personal success over collective effectiveness while overestimating how well their team is functioning.

Gedatolisib is an investigational treatment for patients with HR+/HER2- PIK3CA wild-type advanced breast cancer

Self-administered HPV screening promises greater patient comfort and higher detection rates, though solutions for large-scale rollout and follow-up are still needed.

In this interview, Abbey Berenson, M.D., MMS, Ph.D., director for the Center of Interdisciplinary Research in Women's Health at the University of Texas Medical Branch, discusses the potential of self-swabbing for HPV screening to improve early detection of cervical cancer, particularly for underserved populations, while emphasizing the necessity of follow-up with healthcare providers.

A study using global health records reports that color-blind individuals face higher bladder cancer mortality, potentially due to delayed detection of blood in urine, while no similar survival difference is seen in colorectal cancer.

In 2024, U.S. health care spending rose to $5.3 trillion, driven by increased per capita use and demand for medical services as utilization rebounded following the COVID-19 pandemic.

A long-term UK Biobank analysis shows that while early or surgical menopause initially appears linked to higher diabetes rates, this association disappears after accounting for lifestyle and cardiovascular risk factors rather than menopause timing itself.

United States health care spending rose to $5.3 trillion in 2024, accounting for 18% of the economy, as strong post-pandemic demand and high insurance coverage continued to drive costs upward.

A recent study found that TikTok videos about breast cancer screening created by physicians are more accurate and reliable than those made by nonphysicians or private clinics, highlighting both the platform’s growing role in health education and persistent quality gaps.

A nationwide randomized study showed that risk-based breast cancer screening safely detects cancer while reducing unnecessary screening for low-risk women and is favored by most patients over annual mammograms.

Despite widespread exposure to breast cancer misinformation that heightened fear in many patients, a survey found it did not lead to increased treatment nonadherence.

Numerous medical societies and experts have labeled the CDC’s decision as dangerous and confusing.

In 2024, 91% of patients receiving care through the Ryan White HIV/AIDS Program were virally suppressed, underscoring the program’s role in improving HIV outcomes.

New guidelines from the Health Resources and Services Administration (HRSA) aim to reduce cost and access barriers for detecting human papillomavirus, which is preventable.

Universal recommendations dropped include vaccines for COVID-19 and flu shots.

Long-term Medicaid expansion was linked to substantial growth in PrEP prescribing, with earlier expansion states seeing far higher PrEP uptake relative to new HIV diagnoses, according to a recent study.

Here’s what you missed this week on Managed Healthcare Executive.

The Residual Transformer Generative Adversarial Network (RRTGAN) generates high-quality, cellular-level retinal images from minimal data inputs, overcoming the limitations of previous slow and burdensome imaging methods.

Kyverna’s investigational CAR-T therapy, mivocabtagene autoleucel (miv-cel) showed clinically meaningful mobility improvements in most stiff-person syndrome patients, prompting the company to plan an FDA BLA submission in 2026.

Falls among older adults with visual impairment are strongly linked to modifiable home hazards—especially broken flooring and tripping risks—while fall risk remains relatively low in hazard-free homes.

Despite widespread awareness of shingles risk factors, fewer than one-third of U.S. primary care physicians are fully aware of current ACIP shingles vaccine recommendations, highlighting the need for improved education and implementation.

A new influenza strain could fuel a severe flu season while a surge in measles cases threatens U.S. elimination status, emphasizing that vaccination remains critical to limiting disease spread and severity, according to faculty from Johns Hopkins Bloomberg School of Public Health.

Addyi is the first FDA-approved treatment for low libido in women ages 65 and younger.

A study of more than 1 million UK medical records found that getting a flu vaccine between ages 40 and 50 did not increase Parkinson’s disease risk and was even associated with a lower estimated prevalence eight years later, suggesting a possible protective effect that warrants further research.

Results from a recent ianalumab treatment trial signal a potential for longer-lasting disease control for patients with primary immune thrombocytopenia.

The CAR T Vision Steering Committee members wish to double the number of eligible patients receiving chimeric antigen receptor (CAR) T-cell therapy by 2030 through disease awareness and sustainable financing options, according to George Eastwood, Executive Director of the Emily Whitehead Foundation and recent CAR T Vision Steering Committee member.

Chimeric antigen receptor (CAR) T-cell therapy can cure certain types of blood cancer, but cost and a general lack of awareness around the therapy are barriers to care, according to George Eastwood, Executive Director of the Emily Whitehead Foundation.

In this interview, George Eastwood, Executive Director of the Emily Whitehead Foundation and CAR T Vision steering committee member discusses barriers and strategies for expanding access to CAR T-cell therapy.